Humacyte Inc Warrant
HUMAW
12 hedge funds and large institutions have $1.02M invested in Humacyte Inc Warrant in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 12 → 12 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
32% less capital invested
Capital invested by funds: $1.49M → $1.02M (-$469K)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JAIC
Josh Arnold Investment Consultant
Edina,
Minnesota
|
+$299K |
| 2 |
LPL Financial
San Diego,
California
|
+$297K |
| 3 |
RL
RPO LLC
Stamford,
Connecticut
|
+$3.07K |
| 4 |
Jane Street
New York
|
+$307 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$37.3K |
| 2 |
DCP
Diameter Capital Partners
New York
|
-$37K |
| 3 |
HF
HRT Financial
New York
|
-$5.7K |
| 4 |
Morgan Stanley
New York
|
-$230 |
| 5 |
AGM
Alpine Global Management
New York
|
-$91 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CH
1
CVI Holdings
Wilmington,
Delaware
| $218K | -$37.3K | -24,313 | -9% |
|
|
JAIC
2
Josh Arnold Investment Consultant
Edina,
Minnesota
| $171K | +$299K | +194,718 | New |
|
|
3
LPL Financial
San Diego,
California
| $170K | +$297K | +193,656 | New |
|
|
LP
4
LMR Partners
London,
United Kingdom
| $161K | – | – | – |
|
|
RL
5
RPO LLC
Stamford,
Connecticut
| $74K | +$3.07K | +2,000 | +2% |
|
|
6
Jane Street
New York
| $50K | +$307 | +200 | +0.4% |
|
7
Verition Fund Management
Greenwich,
Connecticut
| $48K | – | – | – |
|
|
SCM
8
Sio Capital Management
New York
| $45K | – | – | – |
|
|
HF
9
HRT Financial
New York
| $41K | -$5.7K | -3,713 | -7% |
|
|
EAM
10
Exos Asset Management
New York
| $24K | – | – | – |
|
|
PSAMP
11
P. Schoenfeld Asset Management (PSAM)
New York
| $17K | – | – | – |
|
|
12
Morgan Stanley
New York
| $1K | -$230 | -150 | -20% |
|
|
AGM
13
Alpine Global Management
New York
| – | -$91 | -47,500 | Closed |
|
|
DCP
14
Diameter Capital Partners
New York
| – | -$37K | -19,085 | Closed |
|
HUMAW Hedge Fund Activity: Q2 2022 in Review
12 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Humacyte Inc Warrant (HUMAW) for Q2 2022, worth a combined $1.02M — down 32% from $1.49M a quarter earlier.
Fund positioning in HUMAW was balanced in Q2 2022: 2 funds opened new positions, 2 closed out, 2 added to existing stakes and 3 trimmed.
The largest buyer was Josh Arnold Investment Consultant, opening a new position worth an estimated $299K. The largest seller was CVI Holdings, cutting an estimated $37.3K.
- 12 institutional investors held Humacyte Inc Warrant (HUMAW) as of Q2 2022, unchanged from Q1 2022.
- Funds reported $1.02M of Humacyte Inc Warrant stock for Q2 2022, down 32% quarter-over-quarter.
- 2 funds opened new Humacyte Inc Warrant positions in Q2 2022 and 2 closed out, a net change of 0 holders.
- The largest Humacyte Inc Warrant buyer in Q2 2022 was Josh Arnold Investment Consultant, an estimated $299K added.
- The largest Humacyte Inc Warrant seller in Q2 2022 was CVI Holdings, an estimated $37.3K sold.
Based on aggregated 13F filings for Q2 2022.